Advertisement

Quality of life in cancer patients

  • Peter Reizenstein
Editorial
  • 22 Downloads

Conclusions

It is time to begin regarding the quality of life as a parameter equally important in the treatment of tumors as survival duration. Estimates of the quality of life are feasible if methodology is carefully considered, and such estimates should be an integral part of certain clinical trials. Continuing evaluation of performance status, times of hospitalization, quality of life and quality of terminal care should be necessary requirements, and the attitudes and opinions of patients and relatives should be taken into account.

Terminal care is still unsatisfactory in many cases, with a long, febrile, weak, undignified, painful period, sometimes lasting a month or more, preceding death. Medically feasible and ethically acceptable methods of helping these patients must be developed. Hospice principles that the patient is always right and that hospital routine and discipline must yield to the desires of the patient and the relatives during this terminal period can help. It is imperative to improve the terminal quality of life so that prolonged suffering can be prevented.

References

  1. 1.
    Milsted R A V, Tattersall M H N, Fox R M, Woods R L: Cancer chemotherapy—what have we achieved?Lancet i, 1343 (1980).CrossRefGoogle Scholar
  2. 2.
    Bohigas L, Heyrman J, Jessee W F, Jolly D, Net I, Castel A, Pelkonen R M, Perraro F, Reerink E, Reizenstein P, de Schouwer P, Selbman H K, Sheldon G, Simonic M, Sunol R, Wyn Owen J, Vuori H: The principles of quality assurance. Report on a WHO advisory meeting. EURO reports and studies 94 (1983).Google Scholar
  3. 3.
    Fleisher D, Perraro F, Vuori H, Reerink E, Sunol R, Gardini A, Ström G, Timmons K, Reizenstein P: Teaching of quality assurance methods in health care. Report on a WHO advisory meeting. EURO reports, Copenhagen (in press).Google Scholar
  4. 4.
    Schipper H, Levitt M: Measuring quality of life: risks and benefits.Cancer Treatment Rep 69, 1115 (1985).Google Scholar
  5. 5.
    Schipper H, Clinch J, McMurray A, Levitt M: Measuring the quality of life of cancer patients: the functional living index—cancer: development and validation.J Clin Onc 12, 472 (1984).Google Scholar
  6. 6.
    Wagstaff S, Smith O V, Wood P H N: Verbal pain descriptors used by patients with arthritis.Ann Rheum Dis 44, 262 (1985).PubMedCrossRefGoogle Scholar
  7. 7.
    Gruber A, Reizenstein P: Attempts to reduce nausea after 52 cytostatic treatment courses (abstract in Swedish).Sw Phys Natl Conf 41 (1984).Google Scholar
  8. 8.
    Ösby E, Lantz B, Nyberg G, Reizenstein P, Sandesjöö S: The opinions of myeloma and leukemia patients and their relatives on the quality of life and the medical care. Abstract,19th Congr Int Soc of Haemat, Budapest, 420 (1982).Google Scholar
  9. 9.
    Bolund C: Suicide among cancer patients. Abstract,3rd European Conf on Clin Oncol and Cancer Nursing, Stockholm3, 123 (1985).Google Scholar
  10. 10.
    Parbhoo S P, Kelleher S M: An improved technique of scalp hypothermia to prevent adriamycin/mitozantrone induced alopecia in patients with advanced breast cancer. Abstract,3rd European Conf on Clin Oncol and Cancer Nursing, Stockholm3, 902 (1985).Google Scholar
  11. 11.
    Filiberti A, Tamburini M, LaMonica G, Audisio R A: Male sexual dysfunction after surgery for rectal malignancy. Abstract,3rd European Conf on Clin Oncol and Cancer Nursing, Stockholm3, 125 (1985).Google Scholar
  12. 12.
    McLeod R S, Lavery I C, Leatherman J Ret al.: Patient evaluation of the conventional ileostomy.Dis Colon Rectum 28, 152 (1985).PubMedCrossRefGoogle Scholar
  13. 13.
    Marshall H, Porteous C, McMillan I, MacPherson S G, Nimmo W S: Relief of pain by infusion of morphine after operation: does tolerance develop?Br Med J 291, 19 (1985).CrossRefGoogle Scholar
  14. 14.
    Schinebu N: in Wiernik P (ed):Controversies in Oncology. New York, John Wiley (1982).Google Scholar
  15. 15.
    Fletcher N: in Wiernik P (ed):Controversies in Oncology. New York, John Wiley (1982).Google Scholar
  16. 16.
    Kaasa S: Lecture, Stockholm, 15 March (1986).Google Scholar
  17. 17.
    Giertz G: Reduced resistance against euthanasia (in Swedish).Läkartidningen 83, 85 (1986).Google Scholar

Copyright information

© Humana Press Inc. 1986

Authors and Affiliations

  • Peter Reizenstein

There are no affiliations available

Personalised recommendations